A new mechanism of NK cell cytotoxicity activation: the CD40-CD40 ligand interaction.
about
Natural selection of tumor variants in the generation of "tumor escape" phenotypesNKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysisMechanisms of Control of Mycobacterium tuberculosis by NK Cells: Role of GlutathioneA Novel Method for Assessment of Natural Killer Cell Cytotoxicity Using Image CytometryCD40 ligand in CLL pathogenesis and therapySuberoylanilide hydroxamic acid (SAHA) and cladribine synergistically induce apoptosis in NK-LGL leukaemia.A Salmonella typhi OmpC fusion protein expressing the CD154 Trp140-Ser149 amino acid strand binds CD40 and activates a lymphoma B-cell line.Human natural killer cells mediate killing of intracellular Mycobacterium tuberculosis H37Rv via granule-independent mechanisms.LNFPIII/LeX-stimulated macrophages activate natural killer cells via CD40-CD40L interaction.Cell adhesion and polarity during immune interactions.Early hematopoietic zinc finger protein prevents tumor cell recognition by natural killer cellsProspects for CD40-directed experimental therapy of human cancer.New directions in natural killer cell-based immunotherapy of human cancer.Fibroblast heterogeneity: existence of functionally distinct Thy 1(+) and Thy 1(-) human female reproductive tract fibroblasts.Immunotherapy of high-risk acute leukemia with a recipient (autologous) vaccine expressing transgenic human CD40L and IL-2 after chemotherapy and allogeneic stem cell transplantation.Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity.Molecular mechanism and function of CD40/CD40L engagement in the immune system.Allo-reactivity of mesenchymal stem cells in rhesus macaques is dose and haplotype dependent and limits durable cell engraftment in vivo.T-cell-independent antitumor effects of CD40 ligation.Clinical, immunological, and molecular characterization of hyper-IgM syndrome due to CD40 deficiency in eleven patients.The role of natural killer cells and CD8(+) T cells in hepatitis B virus infection.Cancer immunotherapy: activating innate and adaptive immunity through CD40 agonists.A viral, transporter associated with antigen processing (TAP)-independent, high affinity ligand with alternative interactions endogenously presented by the nonclassical human leukocyte antigen E class I molecule.Multivalent rituximab lipid nanoparticles as improved lymphoma therapies: indirect mechanisms of action and in vivo activity.Abnormal CD40 ligand (CD154) expression in human immunodeficiency virus-infected childrenThe therapeutic potential of SA-sCD40L in the orthotopic model of superficial bladder cancer.Signalling via CD70, a member of the TNF family, regulates T cell functions.Apoptotic cells overexpress vinculin and induce vinculin-specific cytotoxic T-cell cross-priming.Induction of immunologic tolerance for transplantation.CD40 expressed on human melanoma cells mediates T cell co-stimulation and tumor cell growth.Human NK cells constitutively express membrane TNF-alpha (mTNFalpha) and present mTNFalpha-dependent cytotoxic activity.Soluble CD40 in the serum of healthy donors, patients with chronic renal failure, haemodialysis and chronic ambulatory peritoneal dialysis (CAPD) patients.Reciprocal activating interaction between natural killer cells and dendritic cells.NK cells blur the frontier between innate and acquired immunity.Control of Mycobacterium tuberculosis growth by activated natural killer cells.Proliferative and cytotoxic response of human natural killer cells exposed to transporter associated with antigen-processing-deficient cells.Interaction between natural killer and dendritic cells: the role of CD40, CD80 and major histocompatibility complex class i molecules in cytotoxicity induction and interferon-gamma production.The Role of NK Cells in Pig-to-Human Xenotransplantation.D-dimer level, in association with humoral responses, negatively correlates with survival of porcine islet grafts in non-human primates with immunosuppression.Interleukin (IL)-23 Stimulates IFN-γ Secretion by CD56bright Natural Killer Cells and Enhances IL-18-Driven Dendritic Cells Activation.
P2860
Q24551158-98D44A4C-364B-4317-9C3B-EBEADCF4F265Q24647094-927A2D6D-4D27-4930-BB48-BC0D95BA4508Q26779214-E52DEC34-0B20-4B62-9FAD-1BBD52785D9AQ27312227-32C50AB0-30A8-4735-96FD-D9962DB81928Q28141882-29AF30F1-2DAC-488D-B846-B953FDCB7462Q30303153-B6BED19A-F3D1-46FE-A6FE-F713F645E63BQ33193416-1E8D591B-E48C-4015-8B5C-A85E3A482C87Q34006469-A1D42D7C-CF46-44EA-877D-A48035D05A6EQ34045515-317F0D5D-8B0B-45AB-8A54-524FDA464321Q34862177-E2C345B1-B31E-499F-8339-4F4C0E4AA2DCQ34973901-F53F0D7A-276B-4998-B159-18217AE2674DQ35028895-5ACF2D34-7144-4F51-82DD-FA9C9CCD00FCQ35093608-37E1C867-79A4-4E0A-8BEE-69A879E94DE9Q35746676-0315170E-F68D-4113-AF78-6F3840927463Q35848688-8BFB8C31-875F-4597-9193-DCDB89F89CEFQ36362633-4A0A4C0C-BD05-4417-9458-CECAAFAA7001Q37474929-F5202BDA-4CEB-456E-B506-55947CAB72F1Q37529754-E1614455-CFB6-4586-9F8F-8453B769D3E9Q38026925-2BFDFCC4-2791-465C-80E8-F92FF539B641Q38152266-D414166B-5D5C-4427-894C-97E302B9E7C9Q38219409-90D95581-27AD-487C-9522-8EB84460B057Q38786054-1DA11EA7-24AC-4FE7-8934-389F15A59206Q39289753-08EDACE5-C5C9-43B3-B91D-78338FF36AA7Q39455947-E19A626E-1971-4E57-AE21-B50347010A59Q39508890-5DCD7A82-EEBD-4324-B153-B18C456A01A1Q39605867-9ED7E10D-457B-48B4-A5C8-88C0B617F5BBQ40540340-441E0425-7DE6-4DB0-B6AB-CDF0CF452941Q40795464-062D4F8E-8ED9-4A66-9456-27113AD736E6Q40827011-135EA72D-EAD3-408C-8CC2-4AE138AC5493Q40876094-95E91736-8AA9-4AEF-A971-234256CEDDE7Q40918910-F7EFDFA9-B263-4CCE-B13A-D3DA75972EA9Q40942308-138EC8EB-0283-4AEE-B4B1-438D3BDF5D82Q41992239-A0ACF137-A079-44E6-AD2D-6319F6F947F8Q42472475-41EE32CF-8132-4EEA-9206-E4932E67D370Q44028839-22A04B54-AE42-40B9-A0D1-E7BC65DB5415Q47210839-50617F86-2849-4AC4-A28E-791B9747068DQ47864723-87CB594B-5C71-47C0-ACBA-AE8BEC680FC0Q48093746-CAB0E6E6-750D-43B9-BE68-03E790B89E4CQ48267319-75369FAD-E8FA-4896-A6E1-3AB8BFA3CD05Q49191767-A89060DA-09DF-4411-96CC-6F25D7D1D2E2
P2860
A new mechanism of NK cell cytotoxicity activation: the CD40-CD40 ligand interaction.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
A new mechanism of NK cell cytotoxicity activation: the CD40-CD40 ligand interaction.
@en
A new mechanism of NK cell cytotoxicity activation: the CD40-CD40 ligand interaction.
@nl
type
label
A new mechanism of NK cell cytotoxicity activation: the CD40-CD40 ligand interaction.
@en
A new mechanism of NK cell cytotoxicity activation: the CD40-CD40 ligand interaction.
@nl
prefLabel
A new mechanism of NK cell cytotoxicity activation: the CD40-CD40 ligand interaction.
@en
A new mechanism of NK cell cytotoxicity activation: the CD40-CD40 ligand interaction.
@nl
P2093
P2860
P50
P356
P1476
A new mechanism of NK cell cytotoxicity activation: the CD40-CD40 ligand interaction
@en
P2093
P2860
P304
P356
10.1084/JEM.185.12.2053
P407
P577
1997-06-01T00:00:00Z